Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
0.7230
+0.0230 (3.29%)
At close: May 12, 2025, 4:00 PM
0.7499
+0.0269 (3.72%)
After-hours: May 12, 2025, 7:10 PM EDT
Nautilus Biotechnology Market Cap
Nautilus Biotechnology has a market cap or net worth of $91.21 million as of May 12, 2025. Its market cap has decreased by -69.62% in one year.
Market Cap
91.21M
Enterprise Value
-18.26M
1-Year Change
-69.62%
Ranking
Category
Stock Price
$0.72
Market Cap Chart
Since March 26, 2021, Nautilus Biotechnology's market cap has decreased from $117.04M to $91.21M, a decrease of -22.07%. That is a compound annual growth rate of -5.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 88.30M | -58.14% |
| Dec 31, 2024 | 210.95M | -43.54% |
| Dec 29, 2023 | 373.66M | 66.44% |
| Dec 30, 2022 | 224.50M | -65.10% |
| Dec 31, 2021 | 643.18M | 449.56% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |